Electric convulsive therapy (ECT) increases plasma and red blood cell haloperidol neuroleptic activities
Authors:
- Anri AobaAAAnri Aoba
- Yasuhide KakitaYKYasuhide Kakita
- Noboru YamaguchiNYNoboru Yamaguchi
- Masahiko ShidoMSMasahiko Shido
- Makiko ShibataMSMakiko Shibata
- Kenichi KitaniKKKenichi Kitani
- Kazuo HasegawaKHKazuo Hasegawa
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 33 (18) , 1797-1803
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Increased permeability of blood brain barrier after electroconvulsive shocks (ECS)Pharmacological Research Communications, 1982
- The use of ECT in the treatment of schizophreniaAmerican Journal of Psychiatry, 1980
- Radioreceptor assay of haloperidol tissue levels in the ratNeuropharmacology, 1980
- The Treatment of Psychotic Major Depressive Disorder with Drugs and Electroconvulsive TherapyJournal of Nervous & Mental Disease, 1979
- Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolitesPsychiatry Research, 1979
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- Diagnostic Criteria for Use in Psychiatric ResearchArchives of General Psychiatry, 1972
- ECT-CHLORPROMAZINE AND CHLORPROMAZINE COMPARED IN THE TREATMENT OF SCHIZOPHRENIAJournal of Nervous & Mental Disease, 1967
- COMPARISON OF FOUR REGIMENS IN NEWLY ADMITTED FEMALE SCHIZOPHRENICSAmerican Journal of Psychiatry, 1964